Training

Global Oncology

A New Generation

Fred Hutch Global Oncology is helping build the next generation of African oncologists, researchers and other medical professionals to address the rising cancer burden, particularly in low-and middle-income countries. Through our partnership with the UCI, we are supporting the training of Ugandan oncologists and medical professionals through distinguished fellowships, primarily supported through the National Institutes of Health and through private contributions.

Featured Trainees

Margaret (“Maggie”) Lubwama

Dr. Margaret (“Maggie”) Lubwama

Photo by Robert Hood / Fred Hutch News Service

Margaret (“Maggie”) Lubwama, MBChB, MMed
2015-present
Global Oncology D43 Training Grant PhD Candidate

Dr. Lubwama joined Fred Hutch Global Oncology for a one-year training position to begin her PhD program in Seattle through the collaboration between Fred Hutch and Makerere University in Uganda. She is a medical microbiologist and assistant lecturer at Makerere University. During her Master of Medicine program at Makerere University, Dr. Lubwama studied bacteria and fungi that cause blood infections in cancer patients at the Uganda Cancer Institute and became interested in researching antibiotic resistance among cancer patients. Cancer patients often become immunocompromised and develop secondary infections; particularly vulnerable are people living with HIV who develop HIV-associated cancers. While in Seattle, Dr. Lubwama will develop her research proposal to expand her original study to identify the common pathogens and their antimicrobial susceptibility patterns and to examine risk factors that predispose patients with hematologic malignancies to infection with the aim of informing treatment and infection control and prevention strategies at UCI, and to study antibiotic resistance among cancer patients in Uganda.  

Dr. Lubwama's story


Dr. Nixon Niyonzima

Dr. Nixon Niyonzima

Photo by Robert Hood / Fred Hutch News Service

Nixon Niyonzima, PhD, MBChB, MSc
2012-2016
Global Oncology & UW MCB PhD Candidate

Dr. Niyonzima was a doctoral student within the program in Molecular and Cellular Biology offered in collaboration between the University of Washington and the Fred Hutchinson Cancer Research Center in Seattle. His dissertation focused on the eradication of the latently integrated HIV viral reservoir using engineered endonucleases in the laboratory of Dr. Keith Jerome. While in Seattle, Nixon also received training as a Senior Fellow in Laboratory Medicine at the University of Washington. Dr. Niyonzima is also developing a pilot course in virology for Makerere University, College of Health Sciences in Kampala, with the intention that the course will be accepted as an ongoing offering at the university. Prior to beginning his training with Global Oncology, Dr. Niyonzima was a medical officer at the Uganda Cancer Institute and received a Master of Science in Global Health from Duke University where he studied Kaposi Sarcoma. Dr. Niyonzima returned to Uganda in late 2016 as a Post-Doctoral Research Fellow, where he is continuing his independent molecular virology laboratory research at the UCI – Fred Hutch Cancer Centre, work to optimize laboratory diagnostics for cancer in Uganda and continue to see patients at the UCI. He received his PhD in December 2016 from the University of Washington. 

Dr. Niyonzima's story | Publications


Dr. James Kafeero

Dr. James Kafeero

Photo courtesy of Warren Phipps

James Kafeero, MBChB, MPH
2011-Present
Global Oncology D43 Training Grant MPH Candidate

Dr. Kafeero is one of Global Oncology’s fully-funded Master of Public Health (MPH) candidates. He was selected in 2011 to participate in a MPH program at Makerere University, College of Health Sciences. His research focuses on the delays in obtaining care at the UCI for treatment of Kaposi Sarcoma, and he is expected to complete the program in January 2016. Additionally, Dr. Kafeero serves as a Research Officer with the Hutchinson Center Research Institute-Uganda and sees oncology patients at the UCI in Kampala. He facilitates monthly journal clubs for clinical and research staff at the UCI and Fred Hutch Global Oncology. Upon completion of his training, Dr. Kafeero hopes to pursue specialty medical training in pursuing a Masters of Medicine (MMed) and continue to focus on patient-oriented cancer care research in Uganda.

Read Dr. Kafeero’s story  


Henry Ddungu, MBChB, MMed
2011 – Present
Global Oncology D43 Training Grant PhD Candidate

Dr. Ddungu is one of Global Oncology’s fully-funded PhD candidates, with additional funding from the Northern Pacific Global Health Fellows Training Consortium (R25 TW009345). He was selected in 2010 to participate in a unique program to confer a PhD from the Makerere University College of Health Sciences in conjunction with courses taken at the University of Washington. Dr. Ddungu’s first portion of his PhD training included a 12-month visit to the Fred Hutch, during which he completed one year of graduate level course work at the University of Washington and also participated in clinical oncology rotations at the Seattle Cancer Care Alliance, and UW Harborview Medical Center. Since returning to Kampala in 2012, Henry has continued his PhD studies at Makerere University (anticipated completion January 2016), in which his dissertation is a quality improvement study examining the optimal use of platelet transfusion for oncology patients at the UCI. While working on his dissertations, Dr. Ddungu also sees oncology patients at the UCI in his role as a Hematologist and is also Director of Laboratory Operations.
Upon completion of his training, Dr. Ddungu will take a leadership role in the care of patients through the UCI | Hutchinson Center Cancer Alliance and will continue to conduct patient-oriented research in hematologic malignancies in Uganda.

Read Dr. Ddungu's story

Learn more about Dr. Ddungu's work

Emmanuel Seremba, MBChB, MMed
2011 – Present
Global Oncology D43 Training Grant PhD Candidate

Dr. Seremba is one of Global Oncology’s fully-funded PhD candidates. In 2011, he was selected for a unique PhD program at the Makerere University, College of Health Sciences, in conjunction with courses taken at the University of Washington. Dr. Seremba’s first portion of his PhD training included a 13-month visit to Fred Hutch, during which he completed one year of graduate-level course work at the University of Washington and also participated in clinical oncology rotations at the Seattle Cancer Care Alliance, UW, Harborview Medical Center, Seattle Children’s Hospital and Virginia Mason Hospital. He finalized his research protocol with a two-pronged approach on HBV incidence and vaccination among HIV-infected adult Ugandans. Since returning to the Kampala in 2012, he has continued his research and PhD studies at Makerere University (anticipated completion summer 2016).

Dr. Seremba is also the Chief of Gastroenterology Division in charge of the Digestive Disease Clinic as well as training medical doctors, clinical officers and registered nurses in HIV care and infectious diseases at Makerere University.

Publications
 


Adriane Kamulegeya, MBChB, DDS, MSc
2011 – 2015
Global Oncology D43 Training Grant HIV-Associated Malignancy Fellow

Dr. Kamulegeya joined Global Oncology in 2011 and completed a one-year, graduate-level rotation in Seattle, focused on epidemiology and biostatistics. During this program he conducted research aimed at improving the diagnosis and initial management of Burkitt lymphoma in Uganda. After returning to Kampala, he currently serves as an Oral Surgeon at Mulago National Referral Hospital and Lecturer at Makerere University Department of Dentistry.

Publications
 


Joan N. Mutyoba, MBChB, MS
2011 – 2012
Global Oncology D43 Training Grant HIV-Associated Malignancy Fellow

Dr. Joan N. Mutyoba joined Global Oncology as a Fellow in 2011 and completed a one-year, graduate-level rotation in Seattle, focused on Epidemiology, Biostatistics, and Cancer Epidemiology & Prevention Research. During this program, she developed a research proposal in collaboration with a Fred Hutch/University of Washington mentor to study whether dietary supplementation improves response to treatment and survival among children with lymphoma. Through the fellowship, she aimed to strengthen her research methodology skills to help her apply for independent funding. After returning to Kampala, she has continued her position as Lecturer with the Department of Epidemiology and Biostatistics, Makerere University School of Public Health. In the summer of 2014, Global Oncology selected Dr. Mutyoba to receive a one-year pilot research supplement to further develop a research protocol on prevention of Hepatitis B virus infection among Ugandan pregnant women and children.

Publications | Additional Publications
 


Dr. Noleb Mugisha

Dr. Noleb Mugisha

Photo by Robert Hood / Fred Hutch News Service

Noleb Mugisha, MBChB, MPH, MMed
2010-2012
Global Oncology D43 Training Grant HIV-Associated Malignancy Training Program MPH Awardee
2015-2019 (enrolled)
NIH D43 Training Grant PhD Candidate

Dr. Mugisha has participated in multiple trainings with Fred Hutch Global Oncology. Initially, he was the first fellow in the HIV Associated Malignancy Training Program between 2010-2012, during which he obtained a Master of Public Health (MPH) with a focus on Leadership, Policy and Management from the University of Washington. During his training, his Master’s thesis focused on the predictors of late presentation of cervical cancer in HIV-positive Ugandan women. Following his MPH, Dr. Mugisha completed his Master of Medicine in degree in Family Medicine at Stellenbosch University. He is currently a Research Investigator with the UCI / Hutchinson Center Cancer Alliance, Head of the Comprehensive Community Cancer Program at the UCI, and a Lecturer in the Department of Family Medicine at Makerere University. In 2015, Dr. Mugisha was awarded a highly competitive Conquer Cancer grant from the American Society of Clinical Oncology and began his PhD training as one of Global Oncology’s NIH International Research Training Grant (D43) fellows. Finally, Dr. Mugisha serves as an investigator on a NIH program project grant focused on understanding the predictors of response to treatment for HIV-associated cervical cancer in Uganda (U54 CA190146 Project 3).  

Dr. Mugisha's story


Anthony Natif, BPharm, MPH
2010-2011
Global Oncology D43 Training Grant HIV-Associated Malignancy Training Program Fellow (Pharmacy Focus)

Mr. Natif completed a pharmacy-focused, 13-month oncology fellowship through the HIV-Associated Malignancy Training Program with Fred Hutch. His research focused on factors associated with non-adherence to chemotherapy among patients with HIV-associated malignancies treated at the UCI. Utilizing the skills he received through this coursework, pharmacy preceptorships and leadership development, Mr. Natif completed his Master of Public Health in Leadership, Policy and Management through the Department of Global Health at the University of Washington in 2014. He returned to Uganda and is establishing a small chain of pharmacies in Kampala. He regularly interacts with his colleagues at the UCI and aims to maximize the delivery of chemotherapy and other medications to support oncology care at the UCI.
 


Dr. Abrahams Osmoding

Dr. Abrahams Omoding

Photo by Robert Hood / Fred Hutch News Service

Abrahams Omoding, MBChB, MMed
2010-2011
Global Oncology D43 Training Grant HIV-Associated Malignancy Training Program Fellow

Dr. Omoding completed the HIV-Associated Malignancy Training Program Fellowship at Fred Hutch from 2010 to 2011. He is currently the Director of Outreach and an Attending Physician at the UCI, where he serves as a medical oncologist. As a research Medical Officer with the Hutchinson Center Research Institute-Uganda, he continues to advise and collaborate with Fred Hutch Global Oncology. Through his advocacy efforts on improving awareness of cancer prevention and treatment among Ugandans, the UCI established two rural clinics resulting in more than 700 early stage referrals to the UCI. Dr. Omoding has been an integral part of the UCI’s expansion of inpatient oncology operations to a new six-floor clinical ward. Dr. Omoding is a co-investigator implementing the molecular signatures of successful cellular immune response to NHL (U54 CA190146 Project 2).

Dr. Omoding's story | Publications


Dr. Fred Okuku

Photo by Robert Hood/Fred Hutch News Service

Fred Okuku, MBChB, MMed
2009-2010
Global Oncology D43 Training Grant HIV-Associated Malignancy Training Program Fellow

Dr. Okuku participated in the HIV-Associated Malignancy Training Program between 2009-2010, where he took graduate classes at the University of Washington Schools of Medicine and Public Health and participated in clinical rotations at the Seattle Cancer Care Alliance. Also during his fellowship, Dr. Okuku developed a research project to establish a clinical staging system for African endemic Kaposi sarcoma. In March of 2013, Dr. Okuku received independent funding through a two-year startup catalytic grant, “Beginning Investigator Grant for Catalytic Research” (BIG Cat) from the African Organization for Research and Training in Cancer (AORTIC) and the National Cancer Institute. He presented research to the joint NCI/AORTIC conference in November 2013 in Durban, South Africa. Since returning to Kampala, he has become the Director of Education and continued his work as an Attending Physician in medical oncology at the UCI. As part of the Global Oncology team, he is a research investigator with HCRI-UG and co-facilitates a monthly clinical care and teaching exchange conference between researchers at the UCI and Fred Hutch. In 2015, Dr. Okuku became a Co-Investigator on a project grant to study the relationship between HHV-8 genomic variability and the natural history of Kaposi sarcoma (U54 CA190146 Project 1).

Dr. Okuku's story | Publications


Dr. Innocent Mutyaba

Dr. Innocent Mutyaba

Photo by Robert Hood / Fred Hutch News Service

Innocent Mutyaba, MBChB, MMED
2009-2010
Global Oncology D43 Training Grant HIV-Associated Malignancy Training Program Fellow
2015-2019 (enrolled)
NIH D43 Training Grant PhD Candidate

Dr. Mutyaba has had multiple training opportunities with Fred Hutch Global Oncology. First, he was an HIV-Associated Malignancy fellow between 2009-2010, where he took graduate classes at the University of Washington Schools of Medicine and Public Health and participated in clinical rotations at the Seattle Cancer Care Alliance. Dr. Mutyaba conducted research to understand the relationship between the use of antiretroviral therapy and cancer incidence in Uganda. After returning to Uganda, he became Global Oncology’s Burkitt Lymphoma Project Study Coordinator and matriculated the Master of Medicine program at Makerere University (expected award date of January 2016). In March 2011, he became Global Oncology’s first Ugandan fellow to receive independent funding through a two-year startup catalytic grant, “Beginning Investigator Grant for Catalytic Research” (BIG Cat), from the African Organization for Research and Training in Cancer (AORTIC) and National Cancer Institute. He presented his research through a poster session on access to cancer chemotherapy and predictors of early mortality for childhood cancers in Kyadono country, Uganda at AORTIC’s 2013 annual meeting in Durban, South Africa. In the summer of 2014, Global Oncology selected Dr. Mutyaba to receive a one-year research pilot supplement to develop his research concept regarding asymptomatic malaria parasitemia and Epstein Barr virus in Ugandan children. In June 2015, Dr. Mutyaba was selected as the NIH’s International Research Training Grant (D43) PhD candidate supported by Global Oncology with the degree to be conferred in January 2019 by Makerere University.

Dr. Mutyaba's story | Publications


Amos Mwaka

Dr. Amos Mwaka

Photo from Fred Hutch files

Amos Mwaka, MBChB, MMed, MA
2008-2009
Global Oncology D43 Training Grant HIV-Associated Malignancy Training Program Fellow

Dr. Mwaka participated in the HIV-Associated Malignancy Training Program as a Senior Fellow between 2008 and 2009. His research concentrated on survival after diagnosis of Hodgkin’s Lymphoma at the Uganda Cancer Institute. Currently, Dr. Mwaka is a Lecturer in Medicine at Makerere University College of Health Sciences and finishing his PhD through the Training Health Researchers into Vocational Excellence in East Africa (THRiVE) and Cambridge University. His thesis is focused on cervical cancer in Uganda. Dr. Mwaka is an advocate for improving HIV-associated cancer prevention, care and education in Uganda.

Dr. Mwaka's story | Publications
 


Dr. Victoria Walusana

Dr. Victoria Walusana

Photo by Robert Hood / Fred Hutch News Service

Victoria Walusansa, MBChB, MMed
2007-2008
Global Oncology D43 Training Grant HIV-Associated Malignancy Training Program Fellow

In 2007, Dr. Walusansa became Fred Hutch Global Oncology’s first fellow from the HIV-Associated Malignancy Training Program. During her fellowship, she developed a research proposal on valganciclovir as an adjunct to chemotherapy for treatment of Kaposi sarcoma. Dr. Walusansa is currently the Deputy Director and Head of Clinical Services at the Uganda Cancer Institute and Lecturer in Medicine at Makerere University, College of Health Sciences in Kampala.

Dr. Walusana's story | Publications